Thus, attempts were made to restore RECK expression using DNA methyltransferase (DNMT) inhibitor, 5-aza-2′deoxycytidine (5-aza-dC), in colon cancer and salivary adenoid cystic carcinoma [60, 61]. Here, DNMT1 is linked to colonic neoplasm.